Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

JP Morgan's Dimon finishes scheduled cancer treatments: WSJ

Published 09/11/2014, 12:08 PM
Updated 09/11/2014, 12:20 PM
© Reuters JPMorgan Chairman and CEO Jamie Dimon speaks at the Aspen Institute's "Closing the Workforce Skills Gap" seminar

(Reuters) - JPMorgan Chase & Co CEO Jamie Dimon, who was diagnosed with throat cancer this year, finished his scheduled rounds of radiation and chemotherapy treatment this week, the Wall Street Journal said, citing people familiar with the matter.

Doctors will monitor Dimon, who started treatment about eight weeks ago, to determine if he is cancer-free, the Journal reported. (http://on.wsj.com/1uoGc8S)

Dimon is expected to host the company's third quarter earnings call next month, when he also plans to resume international travel and client meetings, the Journal said.

"I took naps when I had to, went home early, and there were days when I was in treatment all day long," Dimon told the Journal in his first interview since his diagnosis became public.

He said he followed the advice he gives family, friends and employees to "take care of your health first."

At an investor conference this week, the Chief Financial Officer Marianne Lake said Dimon was "feeling fine" with his treatment for throat cancer and was continuing to be involved with the business.

JPMorgan, the biggest U.S. bank by assets said in July that Dimon, 58, was diagnosed with throat cancer but that the ailment was curable.

(Reporting by Avik Das in Bangalore; Editing by Joyjeet Das)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.